news, journals and articles from all over the world.
SEATTLE — April 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. April is National Minority Health Month, with a focus on the disproportionate impacts of COVID-19 on communities of color. See more details below on related Fred Hutch programming.Save the date for our monthly public science event, “Science Says” on Tuesday, April 27.
Read more
More and more Americans are becoming vaccinated against COVID-19, but headlines warn that the number of cases is rising. What’s up with that?
Read moreThe vaccinator workforce is an essential component of the COVID-19 response and recovery. However, since administration of the two FDA-authorized COVID-19 vaccines began in December 2020, the rollout has encountered several challenges and failed to meet initial targets for total vaccinations provided. The current health workforce has been identified as one possible bottleneck for distributing the vaccine, prompting a general call to authorize as many healthcare professionals to administer the vaccine as possible. To track this fast-moving issue at the state level, researchers at the Fitzhugh Mullan Institute for Health Workforce Equity have created an interactive tool that displays temporary, emergency state policies authorizing specific professions to provide the COVID-19 vaccine.
Read more
On Feb. 22, the University of California San Diego brought together a panel of industry experts and esteemed faculty to kick off the university’s “Evenings of Nonconventional Wisdom” online event series hosted in celebration of the university’s 60th anniversary. To continue the timely dialogue around COVID-19 and vaccines, we reached back out to a few of the event panelists plus a leader from UC San Diego’s Return to Learn Program Dr. Robert “Chip” Schooley to answer questions submitted by the audience.
Read more
With topics ranging from the food we eat, the air we breathe, and the land we dwell on to the health of our body and mind, and the well-being of all things in the universe, this is a program that is for everyone and anyone. So, stay tuned and listen LIVE on Chula Radio Plus
Read more
As the COVID-19 vaccine becomes more readily available to people across the country, many patients living with multiple sclerosis (MS), an often debilitating autoimmune disease of the central nervous system, are questioning whether patients on certain medications should get the shot.
Read more
Last fall, many older adults were on the fence about getting a COVID-19 vaccine, according to a poll taken in October. But a new poll taken in late January shows a large uptick in positive attitudes, including among people over 50 who are Black, Hispanic or in fair or poor health.
Read moreThe approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions.
Read moreIn a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Read more
The principal investigators of the Moderna and Johnson & Johnson COVID-19 vaccine clinical trials at Rutgers discuss how the university became a site and their challenges and successes. The Rutgers J&J trial site was the second-largest clinical trial for the company.
Read moreProof of vaccination against COVID-19 i.e. “immunity passports” promise a way to return to a more normal social and economic
Read moreWith scheduling and shipment problems and bad weather delaying second doses of the COVID-19 vaccination, Rutgers scholar Reynold Panettieri is
Read more
While the Johnson & Johnson single-dose COVID-19 vaccine that has now received emergency use authorization by the U.S. Food and Drug Administration has a lower efficacy rate compared to other previously approved vaccines, an expert with The University of Texas Health Science Center at Houston (UTHealth) explains why it is still a significant step toward ending the COVID-19 pandemic.
Read moreSeveral proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.
Read moreThe George Washington University is a site for a phase 2 clinical trial for Sanofi’s adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Read more
For some people, anxiety over what may happen after they get the COVID-19 vaccine seems to almost outweigh the relief of getting protected. Here are some common questions and answers that should ease concerns.
Read moreThe webinar “Disseminating Facts, Dispelling Myths – Building COVID Vaccine Confidence in Communities” hosted by the American Journal of Nursing (AJN) explores why many Americans are hesitant to receive a COVID-19 vaccination and looks at the primary reasons for worry, including misinformation about side effects, lack of trust, and the rapid development of the vaccines.
Read moreRich nations should not engage in “vaccine nationalism” and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York.
Justin Brandt, an assistant professor in the Division of Maternal Fetal Medicine at Rutgers Robert Wood Johnson Medical School and director of quality and safety for the department of OB/GYN, talks about the information provided by the Centers for Disease Control and Prevention and what pregnant women should consider when deciding whether to get the COVID-19 vaccine.
Rutgers medical faculty who have received their second COVID-19 vaccination discuss their side effects and give advice for those still to be vaccinated
Read more
Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson’s COVID-19 vaccine, which applied for emergency use authorization today from the U.S. Food and Drug Administration.
Read moreSEATTLE —Feb. 4, 2021 —Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.We are looking forward to the Transplantation & Cellular Therapy Meetings, to be held online Feb. 8-12. Read highlights of Fred Hutch research to be presented, including on COVID-19 and cancer and new insights on treating graft-vs.
Read moreThe AANEM Quality & Patient Safety Committee has published the paper, “Doctor – Should I get the COVID-19 vaccine? Infection and Immunization in Individuals with Neuromuscular Disorders.”
Read moreJustin R. Ortiz, MD, MS Dr. Ortiz is board certified in internal medicine, pulmonary medicine, and critical care medicine. He
Read more
The images are popping up on our social media feeds: pictures of friends, coworkers, and family members proudly displaying their
Read moreYour corner pharmacy will play a big role in delivering the COVID-19 vaccine and sharing important info with the public,
Read more
Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
Read moreThe National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.
Read moreAs the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.
Read more
By: Bill Wellock | Published: January 13, 2021 | 2:12 pm | SHARE: New variants of the COVID-19 virus have appeared around the world, including a more contagious variant of the COVID-19 virus that was first identified in the United Kingdom. Other variants have been identified in South Africa, Nigeria and Japan.Viruses constantly change through mutation.
Read moreWhile we wait for our turn to get vaccinated against SARS-CoV-2, we could – and probably should – use the time to make sure we bring our healthiest emotional and physical selves to the treatment, a new review of previous research suggests.
Read moreAs the vaccine becomes available to older adults, and case of COVID-19 surge, a list of key tips and relevant links for older adults about getting through this winter safely and healthily.
Read more
Is the COVID-19 vaccine safe for people with food allergies? Two infectious disease experts offer answers and explain how the body accepts the vaccine in this week’s Penn State Health Medical Minute.
Read moreKeck Medicine of USC to provide COVID-19 update on staff vaccinations; future patient and community efforts
Read moreEven as vaccinations against COVID-19 are under way, the virus continues to kill thousands of Americans every day, making it more important than ever to stay safe and be ready in case it strikes you or your family. Here’s what you need to do to prevent and prepare for the novel coronavirus.
Read moreWhen Joni Stokx, RN, heard that the COVID-19 vaccine was coming, it brought her to tears. A nurse at Cedars-Sinai Marina del Rey Hospital, she’s been caring for COVID-19 patients for 10 months. While she and her co-workers wear all the recommended personal protective equipment (PPE) and take lots of precautions, getting the vaccine will help her feel safer.
Read moreRutgers medical experts are available to discuss the FDA’s approval of Moderna’s coronavirus vaccine for emergency use and its rollout.
Read moreFirst UChicago Medicine employees vaccinated against SARS-CoV-2; Paves way for thousands more to be scheduled over next several weeks
Read more
The first wave of Cedars-Sinai staff members are receiving the much-anticipated COVID-19 vaccine Thursday morning, an occasion that is bringing hope and relief to those who have fought on the medical frontline for nearly a year against the deadly illness.
Read more
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is pleased to announce that more than $145,000 has already been granted by several leading New Jersey headquartered banks and affiliated foundations, including: OceanFirst Bank, Peapack-Gladstone Bank, Manasquan Bank and Valley Bank.
Read moreOn Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19
Read moreWith the first round of COVID-19 vaccines being deployed to states across the country, the American Society of Anesthesiologists (ASA) advises that anesthesia professionals, and other frontline health care workers, be prioritized to receive early access to the COVID-19 vaccination given their high risk of exposure to the virus in operating rooms, labor and delivery suites, procedural areas, emergency rooms and critical care units.
Read moreJoin us for a virtual press conference as Keck Medicine of USC experts discuss how the health system is handling the receipt and distribution of vaccines the day before vaccinations begin.
Read moreRichard Marlink, director of the Rutgers Global Health Institute, is available to discuss the global health impact of coronavirus vaccine
Read more
In a world where conspiracy theories and political polarization abound, how does one effectively pull off double duty at battling against both the spread of COVID-19 and misinformation about it? For answers, we turned to Rebecca Rice, a UNLV Greenspun College of Urban Affairs professor who specializes in crisis communication.
Read morePublic health experts predict the United States may be headed for thousands of new COVID-19 cases and deaths this winter,
Read moreA Rutgers philosopher examines the ethical questions around human challenge trials for COVID-19 vaccines
Read more
Perry N. Halkitis, dean of the Rutgers School of Public Health, is available to discuss the priorities for COVID-19 vaccination
Read moreNearly half of all patients served by community health centers (CHCs) qualify for phase one COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention, according to a new analysis produced by researchers at the Geiger Gibson/RCHN Community Health Foundation Research Collaborative.
Read moreSEATTLE – Dec. 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.If you’re following the American Society of Hematology’s annual meeting (virtual, Dec. 5-8), see our media tip sheet highlighting Fred Hutch presentations and activities, including those by current ASH president Dr.
Read more